title: Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine.
authors.forename: L
authors.initials: L
authors.lastname: Milazzo
authors.forename: S
authors.initials: S
authors.lastname: Rusconi
authors.forename: L
authors.initials: L
authors.lastname: Testa
authors.forename: S
authors.initials: S
authors.lastname: La Seta-Catamancio
authors.forename: M
authors.initials: M
authors.lastname: Galazzi
authors.forename: S
authors.initials: S
authors.lastname: Kurtagic
authors.forename: P
authors.initials: P
authors.lastname: Citterio
authors.forename: M
authors.initials: M
authors.lastname: Gianotto
authors.forename: A
authors.initials: A
authors.lastname: Grassini
authors.forename: F
authors.initials: F
authors.lastname: Adorni
authors.forename: A
authors.initials: A
authors.lastname: d'Arminio-Monforte
authors.forename: M
authors.initials: M
authors.lastname: Galli
authors.forename: M
authors.initials: M
authors.lastname: Moroni
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000145:classification / Q000187:drug effects / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D008969:Molecular Sequence Data; D010641:Phenotype; D011446:Prospective Studies; D012367:RNA, Viral / Q000737:chemistry; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018119:Stavudine / Q000494:pharmacology / Q000627:therapeutic use*; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D018119:Stavudine